NVCT Nuvectis Pharma, Inc.

Fundamentals / CIK 0001875558 / USD

Nuvectis Pharma, Inc. reported $140.8M in total assets and a net loss of $50.45M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NVCT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$24.72MFY 2021 Net Income: -$12.89M2021FY 2022 Net Income: -$19.09M2022FY 2023 Net Income: -$22.26M2023FY 2024 Net Income: -$19.00M2024FY 2025 Net Income: -$26.44M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $18.15M $12.92M $15.38M $13.23M $9.54M
Operating Income -$27.57M -$19.85M -$22.90M -$19.23M -$12.89M
Net Income -$26.44M -$19.00M -$22.26M -$19.09M -$12.89M
Basic EPS -$1.32 -$1.11 -$1.43 -$1.51 -$3.02
Diluted EPS -$1.32 -$1.11 -$1.43 -$1.51 -$3.02
Basic Shares Outstanding 21.8M 17.1M 15.6M 12.7M 4.3M
Diluted Shares Outstanding 21.8M 17.1M 15.6M 12.7M 4.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $27.37M $4.68M $4.11M $5.09M $5.77M $3.61M $3.68M $4.50M
Operating Income -$31.05M -$7.20M -$6.26M -$7.62M -$7.79M -$6.59M -$5.57M -$6.45M
Net Income -$30.07M -$7.02M -$6.05M -$7.31M -$7.46M -$6.33M -$5.33M -$6.25M
Basic EPS -$1.02 -$0.30 -$0.26 -- -$0.44 -$0.30 -$0.27 --
Diluted EPS -$1.02 -$0.30 -$0.26 -- -$0.44 -$0.30 -$0.27 --
Basic Shares Outstanding 29.5M 23.5M 23.4M -- 22.7M 21.4M 19.9M --
Diluted Shares Outstanding 29.5M 23.5M 23.4M -- 22.7M 21.4M 19.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $31.63M $18.53M $19.13M $19.99M $5.74M
Cash & Short-Term Investments $31.63M $18.53M $19.13M $19.99M $5.74M
Other Current Assets $75K $74K $59K $412K $91K
Total Current Assets $31.71M $18.61M $19.18M $20.41M $5.83M
Total Non-Current Assets $0 $0 $0 $0 $824K
Total Assets $31.71M $18.61M $19.18M $20.41M $6.66M
Accounts Payable $6.27M $2.50M $2.77M $2.91M $1.06M
Total Current Liabilities $13.30M $8.89M $6.98M $6.19M $2.42M
Total Non-Current Liabilities $0 $0 $0 $0 $0
Total Liabilities $13.30M $8.89M $6.98M $6.19M $2.42M
Retained Earnings -$99.69M -$73.25M -$54.24M -$31.98M -$12.90M
Total Stockholders' Equity $18.41M $9.71M $12.20M $14.22M -$11.01M
Total Equity $18.41M $9.71M $12.20M $14.22M -$11.01M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $140.7M $22.16M $25.13M $31.63M $35.44M $26.79M $29.86M $18.53M
Cash & Short-Term Investments $140.7M $22.16M $25.13M $31.63M $35.44M $26.79M $29.86M $18.53M
Other Current Assets $132K $216K $268K $75K $145K $214K $284K $74K
Total Current Assets $140.8M $22.38M $25.40M $31.71M $35.59M $27.01M $30.15M $18.61M
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $140.8M $22.38M $25.40M $31.71M $35.59M $27.01M $30.15M $18.61M
Accounts Payable $5.76M $5.18M $4.70M $6.27M $6.44M $4.98M $2.99M $2.50M
Total Current Liabilities $14.19M $13.29M $11.18M $13.30M $11.58M $10.13M $9.19M $8.89M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $14.19M $13.29M $11.18M $13.30M $11.58M $10.13M $9.19M $8.89M
Retained Earnings -$142.8M -$112.8M -$105.7M -$99.69M -$92.37M -$84.91M -$78.58M -$73.25M
Total Stockholders' Equity $126.6M $9.08M $14.22M $18.41M $24.01M $16.87M $20.95M $9.71M
Total Equity $126.6M $9.08M $14.22M $18.41M $24.01M $16.87M $20.95M $9.71M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.44M -$19.00M -$22.26M -$19.09M -$12.89M
Stock-Based Compensation $6.03M $4.86M $4.71M $1.71M $1.89M
Change in Payables $3.78M -$273K -$139K $1.85M --
Operating Cash Flow -$16.01M -$12.25M -$15.95M -$13.56M -$9.50M
Investing Cash Flow -- $0 $0 $0 --
Common Stock Issued -- $12.04M $5.29M -- --
Financing Cash Flow $29.11M $11.65M $15.09M $27.81M $15.25M
Net Change in Cash $13.10M -$593K -$867K $14.25M $5.74M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$30.07M -$7.02M -$6.05M -$7.31M -$7.46M -$6.33M -$5.33M -$6.25M
Stock-Based Compensation $2.42M $1.71M $1.85M $1.48M $1.46M $1.73M $1.37M $1.14M
Change in Payables $577K $489K -$1.58M -$165K $1.46M $1.99M $494K $237K
Operating Cash Flow -$25.28M -$4.53M -$6.51M -$3.97M -$4.49M -$3.37M -$4.17M -$2.46M
Investing Cash Flow -- -- $0 -- -- -- $0 --
Common Stock Issued -- -- -- -- -- -- -- $3.95M
Financing Cash Flow $143.8M $1.56M $7.0K $166K $13.14M $296K $15.51M $3.83M
Net Change in Cash $118.5M -$2.97M -$6.50M -$3.81M $8.65M -$3.07M $11.33M $1.36M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -143.6% -195.6% -182.4% -134.2% --
Return on Assets (ROA) -83.4% -102.1% -116.0% -93.5% -193.6%
Current Ratio 2.38x 2.09x 2.75x 3.30x 2.41x
Quick Ratio 2.38x 2.08x 2.74x 3.23x 2.37x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -39.8% -306.6% -191.0% -143.6% -105.7% -130.8% -96.2% -195.6%
Return on Assets (ROA) -35.8% -124.4% -106.9% -83.4% -71.3% -81.7% -66.9% -102.1%
Current Ratio 9.92x 1.68x 2.27x 2.38x 3.07x 2.66x 3.28x 2.09x
Quick Ratio 9.91x 1.67x 2.25x 2.38x 3.06x 2.64x 3.25x 2.08x
Source: SEC EDGAR CompanyFacts (CIK 0001875558) · from March 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal